Written question asked by Lord Hunt of Kings Heath (Labour) on Monday, 28 October 2019, in the House of Lords. It was due for an answer on Monday, 11 November 2019. It was answered by Baroness Blackwood of North Oxford (Conservative) on Monday, 4 November 2019 on behalf of the Department of Health and Social Care.
Liothyronine
- Question
-
To ask Her Majesty's Government what action they are taking to ensure that the updated prescribing guidance for liothyronine issued by the South Regional Medicines Optimisation Committee in July is followed by all Clinical Commissioning Groups.
- Answer
-
It is not the responsibility of the Department to direct clinical commissioning groups (CCGs) on which medicines they can or cannot prescribe. These decisions need to be taken by each individual CCG. However, we would expect CCGs to have regard to the South Regional Medicines Optimisation Committee prescribing guidance.
Secondary information
- Type
- Written question
- Reference
- HL455
- Session
- 2019-19
- Subjects
- Prescriptions Liothyronine
- Link
- View this Written question on www.parliament.uk
Librarians' tools
- Timestamp
- 2019-12-11 16:32:51 +0000
- URI
- http://data.parliament.uk/writtenparliamentaryquestion/lords/2019-19/HL455
- In Indexing
- http://indexing.parliament.uk/Content/Edit/1?uri=http://data.parliament.uk/writtenparliamentaryquestion/lords/2019-19/HL455
- In Solr
- https://search.parliament.uk/claw/solr/?id=http://data.parliament.uk/writtenparliamentaryquestion/lords/2019-19/HL455